LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

Search

Clearside Biomedical Inc

Fermé

0.88 4.76

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.84

Max

0.89

Chiffres clés

By Trading Economics

Revenu

383K

-7.3M

Ventes

-732K

306K

BPA

-0.1

Marge bénéficiaire

-2,387.582

Employés

32

EBITDA

508K

-4.6M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+574.42% upside

Dividendes

By Dow Jones

Prochains Résultats

14 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-9.5M

69M

Ouverture précédente

-3.88

Clôture précédente

0.88

Score Technique

By Trading Central

Confiance

Neutral Evidence

Clearside Biomedical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 mai 2025, 22:34 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 mai 2025, 23:48 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12 mai 2025, 23:46 UTC

Market Talk

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12 mai 2025, 23:34 UTC

Market Talk

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12 mai 2025, 23:21 UTC

Market Talk

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12 mai 2025, 22:54 UTC

Market Talk

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12 mai 2025, 22:43 UTC

Résultats

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12 mai 2025, 22:14 UTC

Actualités

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 mai 2025, 22:08 UTC

Acquisitions, Fusions, Rachats

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12 mai 2025, 22:08 UTC

Acquisitions, Fusions, Rachats

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12 mai 2025, 22:07 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12 mai 2025, 22:07 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Australia Retail Electricity Business to AGL

12 mai 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12 mai 2025, 22:06 UTC

Acquisitions, Fusions, Rachats

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12 mai 2025, 22:05 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12 mai 2025, 22:04 UTC

Acquisitions, Fusions, Rachats

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 mai 2025, 21:15 UTC

Actualités

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12 mai 2025, 21:01 UTC

Résultats

Constellation Software 1Q Rev $2.65B >CSU.T

12 mai 2025, 21:01 UTC

Résultats

Constellation Software 1Q Net $115M >CSU.T

12 mai 2025, 21:01 UTC

Résultats

Constellation Software 1Q EPS $5.44 >CSU.T

12 mai 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 mai 2025, 20:50 UTC

Market Talk
Résultats

Basic Materials Roundup: Market Talk

12 mai 2025, 20:44 UTC

Actualités

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12 mai 2025, 20:31 UTC

Actualités

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12 mai 2025, 20:24 UTC

Résultats

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12 mai 2025, 20:24 UTC

Résultats

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12 mai 2025, 20:24 UTC

Actualités

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12 mai 2025, 20:22 UTC

Acquisitions, Fusions, Rachats

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12 mai 2025, 20:15 UTC

Résultats

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12 mai 2025, 20:10 UTC

Résultats

Blink Charging 1Q Rev $20.8M >BLNK

Comparaison

Variation de prix

Clearside Biomedical Inc prévision

Objectif de Prix

By TipRanks

574.42% hausse

Prévisions sur 12 Mois

Moyen 5.8 USD  574.42%

Haut 8 USD

Bas 4 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

5

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

0.8417 / 0.8939Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.